Predict your next investment

Venture Capital
medven.com

See what CB Insights has to offer

Investments

125

Portfolio Exits

27

Funds

5

About MedVenture Associates

MedVenture Associates is a venture capital firm specializing in pre-seed, seed, and early stage investments. The firm will also consider later stage where early investment liquidity is anticipated. It seeks to invest in the field of medical technology, including medical devices; ehealth; healthcare services; instrumentation; and medical diagnostic. The firm's secondary investment focus is medical information technology, pharmaceutical, and biotechnology products. For early stage companies, it prefers to invest in Western region of the continental United States, where the firm's management team can reach by air, in two hours or less and for later-stage companies it will invest regardless of geography. The firm seeks to act as a sole or lead founding investor in its portfolio companies. It prefers to take a board seat on its portfolio companies. MedVenture Associates was founded by Ms. Annette J. Campbell-White in 1986 and is based in Emeryville, California.

MedVenture Associates Headquarter Location

5980 Horton Street Suite 390

Emeryville, California, 94608,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest MedVenture Associates News

Investor Profile: MedVenture Associates

Feb 5, 2013

Apple Jan Barker from MedVenture Associates is a member of FundingPost online! Venture Fund Member Profile Share This Profile: The MVA Team has vast experience in the fields of medical technology, including medical devices, instrumentation and medical diagnostic technology, medical information technology, healthcare services, biotechnology, and pharmaceutical products, and selected later stage investments. Investments will be made in these areas where the goal is to create significant, substantial new businesses.To maximize investors' returns, MVA places its greatest emphasis on companies in the earliest stages of start-up, where the best values are usually found. However, the Fund will consider later-stage investments where early investment liquidity appears likely. Jan Barker Member MedVenture Associates Ms. Barker brings wide-ranging experience to the MedVenture Associates team. She has a broad combination of complementary skills in the healthcare entrepreneurial environment. Her diverse experience has included management, research and development, sales and marketing, human resources, information technology, development of e-healthcare technology and systems, devices and manufacturing.Ms. Barker has worked/invested with private and public corporations in the healthcare systems, technology and medical device industries, including IPCM, The Hospitalist Company, PointShare, Networks for Healthcare, Alere Medical, Incorporated. Representative Investments medven-Cardiac.gif Electrophysiology. Mapping and ablation catheters for treatment of arrhythmias. medven-Neuropace.gif Treatment of epilepsy and other neurological disorders medven-Resound.gif Digital hearing aids and related systems medven-Ventritex.gif Implantable defibrillator for treatment of uncontrolled coronary arrhythmias About FundingPost For over Fourteen Years FundingPost has worked with thousandsof Angel and Venture Capital Investors. We believe that it isimportant to reach investors in every medium possible -both online and offline. We have been directly responsible fortons of success stories and Millions and Millions of dollars raised.We look forward to introducing your company to the leading Venture and Angel Investors nationwide. Sign up now: Entrepreneurs / Investors Join the FundingPost email list and learn how, when and where you can meet these Investors: Other Venture Profiles: "FundingPost allows the venture community to review many interesting deals in a short period of time. The consistent format allows VCs to quickly evaluate companies raising capital based on the criteria that's most important to them. " - Deepak Kamra, Canaan Partners "I know that I've invested in at least one deal associated with FundingPost events, and it's a great networking opportunity with the founders and the VCs that are there. I'm looking forward to this one! " - John Filla, Angel Investor, Houston Angel Network "I just invested in a mobile company I met through FundingPost - Thanks! " - Jay Goldberg, Hudson Ventures "Empire Angels has invested in two companies we met through FundingPost. This is a great forum for entrepreneurs to meet investors and we look forward to continued participation! " - Graham Gullans, Empire Angels "FundingPost has provided Investors a great way to read company summaries from across the country, and entrepreneurs the opportunity to get in front of a lot of Venture Funds they wouldn't normally have access to. " - Richard Irving, Pond Venture Partners "I see CEO's get their PhDs in best practices for how-to-get-funded techniques. This is accomplished through FundingPost's well orchestrated and accomplished conferences - great for learning from and networking with the money sources. " - Jeanne M. Sullivan, StarVest Partners "BP's Castrol innoVentures invested in a company we met through FundingPost - They are a great resource for Investors and entrepreneurs alike! " - Miriam C Eaves, BP's Castrol innoVentures "As a result of the conference we attended in Miami, Caerus made one of its first Investments in a Florida-based company whose CEO we met because of the impressive network FundingPost has constructed. " - Zachary A. Cherry, Caerus Ventures LLC "I am happy to be a member of FundingPost.com. We always find good prospects, and the interface is efficient and easy to use. Thanks for putting this together. " - George Petracek, Atrium Capital "The Las Vegas Investor RoundTable of December 2013 was a great event because I got to know many talented entrepreneurs in Las Vegas that I would not have met in person otherwise. After the event, I made an investment of $25,000 in a seed idea that is looking very promising! I am looking forward to future events and future investments in Las Vegas entrepreneurs. " - Don Sorensen, Las Vegas Angel Investor © Copyright 2001-2016 Second Venture Corporation. All Rights Reserved.

MedVenture Associates Investments

125 Investments

MedVenture Associates has made 125 investments. Their latest investment was in Alleviant Medical as part of their Series B on May 5, 2020.

CBI Logo

MedVenture Associates Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/18/2020

Series B

Alleviant Medical

$13M

Yes

2

8/13/2018

Series B

Farapulse

$12M

No

1

2/14/2018

Series E

OptiScan Biomedical

$14.81M

No

1

7/11/2017

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

6/7/2016

Series D

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/18/2020

8/13/2018

2/14/2018

7/11/2017

6/7/2016

Round

Series B

Series B

Series E

Series A - II

Series D

Company

Alleviant Medical

Farapulse

OptiScan Biomedical

Subscribe to see more

Subscribe to see more

Amount

$13M

$12M

$14.81M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

1

10

10

MedVenture Associates Portfolio Exits

27 Portfolio Exits

MedVenture Associates has 27 portfolio exits. Their latest portfolio exit was Farapulse on June 24, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/24/2021

Acquired

$99M

8

4/22/2021

IPO

$99M

2

10/1/2020

IPO

$99M

1

8/14/2019

Asset Sale

Subscribe to see more

Subscribe to see more

10

6/5/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/24/2021

4/22/2021

10/1/2020

8/14/2019

6/5/2018

Exit

Acquired

IPO

IPO

Asset Sale

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

8

2

1

10

10

MedVenture Associates Fund History

5 Fund Histories

MedVenture Associates has 5 funds, including MedVenture Associates IV Annex LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/30/2008

MedVenture Associates IV Annex LP

Late-Stage Venture Capital

Closed

$11M

1

9/9/2004

MedVenture Associates V LP

Subscribe to see more

Subscribe to see more

$99M

10

7/31/2002

MedVenture Associates IV LP

Subscribe to see more

Subscribe to see more

$99M

10

8/1/1998

MedVenture Associates III LP

Subscribe to see more

Subscribe to see more

$99M

10

12/31/1996

MedVenture Associates II LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

9/30/2008

9/9/2004

7/31/2002

8/1/1998

12/31/1996

Fund

MedVenture Associates IV Annex LP

MedVenture Associates V LP

MedVenture Associates IV LP

MedVenture Associates III LP

MedVenture Associates II LP

Fund Type

Late-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$11M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

MedVenture Associates Team

6 Team Members

MedVenture Associates has 6 team members, including current Managing Partner, Annette Campbell-white.

Name

Work History

Title

Status

Annette Campbell-white

Managing Partner

Current

George Choi

Managing General Partner

Former

Charles Liamos

Managing General Partner

Former

Daniel Burnett

General Partner

Former

Duane R Mason

Prism VentureWorks

General Partner

Former

Name

Annette Campbell-white

George Choi

Charles Liamos

Daniel Burnett

Duane R Mason

Work History

Prism VentureWorks

Title

Managing Partner

Managing General Partner

Managing General Partner

General Partner

General Partner

Status

Current

Former

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.